{
  "alleleExist":false,
  "dataVersion":"v4.5",
  "diagnosticImplications":[],
  "diagnosticSummary":"",
  "geneExist":true,
  "geneSummary":"DICER1 is a tumor suppressor and an endoribonuclease. Germline mutations in DICER1 predispose to various cancer types, including pleuropulmonary blastoma, rhabdomyosarcoma, cystic nephroma, ovarian Sertoli-Leydig cell tumor and endocrine tumors.",
  "highestDiagnosticImplicationLevel":null,
  "highestFdaLevel":null,
  "highestPrognosticImplicationLevel":null,
  "highestResistanceLevel":null,
  "highestSensitiveLevel":null,
  "hotspot":false,
  "lastUpdate":"12/22/2022",
  "mutationEffect":{
    "citations":{
      "abstracts":[],
      "pmids":[
        "20305640",
        "22353998",
        "21266384",
        "21501861"
      ]
    },
    "description":"DICER1 germline truncating mutations result in various forms of C-terminally truncated DICER1 protein and the loss of DICER1 protein function. These mutations have been identified in pleuropulmonary blastoma (PMID: 21266384, 21501861). In vitro studies with DICER1-deficient mouse myeloid progenitor cells demonstrated that loss of DICER1 is inactivating as measured by blocked monocyte differentiation, depleted macrophages and induced myeloid dysplasia compared to wildtype (PMID: 22353998, 20305640).",
    "knownEffect":"Likely Loss-of-function"
  },
  "oncogenic":"Likely Oncogenic",
  "otherSignificantResistanceLevels":[],
  "otherSignificantSensitiveLevels":[],
  "prognosticImplications":[],
  "prognosticSummary":"",
  "query":{
    "alteration":"X103_splice",
    "alterationType":null,
    "consequence":"splice_donor_variant",
    "entrezGeneId":23405,
    "hgvs":"14:g.95132514C>T",
    "hugoSymbol":"DICER1",
    "id":null,
    "proteinEnd":103,
    "proteinStart":103,
    "referenceGenome":"GRCh38",
    "svType":null,
    "tumorType":null
  },
  "treatments":[],
  "tumorTypeSummary":"",
  "variantExist":false,
  "variantSummary":"The DICER1 X103_splice alteration is likely oncogenic.",
  "vus":false
}